Cellevate develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3d™ - with the potential to revolutionize upstream bioprocessing from R&D to commercial manufacturing. Our latest product line in development – Cellevat3d™ carriers – with a commercial launch planned for 2024, provides extracellular-like environments with exceptional surface areas for adherent cell cultures. Initial results show tremendous potential to increase yields, minimize risk and reduce costs in development and manufacturing.
We offer a range of products based on our versatile and easily functionalized platform for several applications, including next generation cell- and gene therapies.
For more information, please visit www.cellevate.com
Company Details
- Employees
- 31
- Founded
- -
- Address
- Scheeletorget 1, Lund,skåne 22381,sweden
- Phone
- (+46) 736-333 390
- in****@****ate.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cellevate.com
- Keywords
- Lund.
- HQ
- Lund, Skåne
Cellevate Ab Questions
Cellevate Ab's helpline number is (+46) 736-333 390
Cellevate Ab's website is cellevate.com
Cellevate Ab's LinkedIn profile is https://se.linkedin.com/company/cellevate-ab
Cellevate Ab has
31 employees.
View email and phone details for 31
employees at Cellevate Ab.
Cellevate Ab's industry is
Biotechnology Research
Cellevate Ab's top competitors are
Medicon Village,
Alligator Bioscience Ab,
Bioinvent International Ab,
Truly Labs,
Saromics Biostructures Ab,
Redoxis Ab,
Asgard Therapeutics,
Cantargia Ab,
Haeger & Carlsson | Executive Search And Interim,
Camurus.
Cellevate Ab's support email address is info@cellevate.com
Cellevate Ab's categories are Biotechnology Research
Cellevate Ab's founding year is 2014
